Hikari Power Ltd Sells 6,000 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Hikari Power Ltd reduced its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 38.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,500 shares of the company’s stock after selling 6,000 shares during the period. Hikari Power Ltd’s holdings in Roche were worth $331,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Verity Asset Management Inc. boosted its stake in Roche by 26.8% in the fourth quarter. Verity Asset Management Inc. now owns 8,036 shares of the company’s stock worth $280,000 after purchasing an additional 1,697 shares in the last quarter. Hantz Financial Services Inc. raised its holdings in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after buying an additional 305 shares during the last quarter. Brooklyn Investment Group lifted its position in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after buying an additional 363 shares in the last quarter. Diversified Trust Co grew its holdings in Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after acquiring an additional 711 shares during the last quarter. Finally, Bard Financial Services Inc. increased its position in Roche by 37.7% in the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on RHHBY shares. Morgan Stanley started coverage on Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating for the company. Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a report on Thursday, January 30th. Finally, UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Roche Stock Performance

RHHBY stock opened at $41.42 on Friday. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97. Roche Holding AG has a twelve month low of $29.20 and a twelve month high of $42.43. The business’s fifty day moving average is $37.57 and its 200-day moving average is $38.36.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.